FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080484488> ?p ?o ?g. }

• W2080484488 endingPage "5844" @default.
• W2080484488 startingPage "5837" @default.
• W2080484488 abstract "We report on the evaluation of the immunogenicity and reactogenicity/safety of AS03-adjuvanted vaccine against pandemic influenza A/H1N1/2009 in young children. In this open-label, randomized study, 157 healthy children aged 6–35 months received two doses (21 days apart) of split-virion inactivated A/California/7/2009 H1N1 vaccine containing either (i) 1.9 μg hemagglutinin (HA) and AS03B (5.93 mg tocopherol) (N = 104) or (ii) 3.75 μg HA and AS03A (11.86 mg tocopherol) (N = 53). At 21 days following the first dose of AS03B-adjuvanted vaccine (1.9 μg HA) the percentage of children with hemagglutination-inhibition titers of ≥40 against the vaccine strain rose from 3.0% before vaccination to 100%. The seroconversion rate was 99% and the geometric mean titer (GMT) increased from 6 to 313. After the second dose the GMT increased further to 2008. The higher dose AS03A-adjuvanted 3.75 μg HA vaccine did not further increase the immune response. Solicited symptoms reported within 7 days following vaccination were mainly mild to moderate. After the first dose of AS03B-adjuvanted vaccine (1.9 μg HA) the most common solicited symptoms were pain at the injection site (35.6%) and irritability (31.7%). Fever (axillary ≥37.5 °C) was reported with an incidence of 20.2%. After the second dose reactogenicity tended to increase (injection site pain: 41.3%; irritability: 46.2%; fever ≥37.5 °C: 67.3%). Spontaneously reported adverse events with an intensity that prevented normal activities were documented for 2.9–6.7% of doses with only one event (vomiting) considered related to vaccination. There was one serious adverse event reported in the AS03A-adjuvanted 3.75 μg HA vaccine group (traumatic brain injury) which was not considered as related to vaccination. In conclusion, these data suggest that a first dose of AS03B-adjuvanted A/H1N1/2009 vaccine containing 1.9 μg HA in children 6–35 months old is highly immunogenic and that the overall reactogenicity profile is acceptable although reactions including fever tend to increase after a second dose." @default.
• W2080484488 created "2016-06-24" @default.
• W2080484488 creator A5009849024 @default.
• W2080484488 creator A5010388039 @default.
• W2080484488 creator A5053911746 @default.
• W2080484488 creator A5057302487 @default.
• W2080484488 creator A5064375375 @default.
• W2080484488 creator A5076616385 @default.
• W2080484488 creator A5085621907 @default.
• W2080484488 creator A5091003508 @default.
• W2080484488 date "2010-08-01" @default.
• W2080484488 modified "2023-09-27" @default.
• W2080484488 title "Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months" @default.
• W2080484488 cites W1970911316 @default.
• W2080484488 cites W1971932580 @default.
• W2080484488 cites W1974031846 @default.
• W2080484488 cites W1974114500 @default.
• W2080484488 cites W1983669467 @default.
• W2080484488 cites W1985582011 @default.
• W2080484488 cites W1986317774 @default.
• W2080484488 cites W1987783718 @default.
• W2080484488 cites W1990014391 @default.
• W2080484488 cites W2011879952 @default.
• W2080484488 cites W2017046353 @default.
• W2080484488 cites W2031180239 @default.
• W2080484488 cites W2039583380 @default.
• W2080484488 cites W2045584501 @default.
• W2080484488 cites W2047370146 @default.
• W2080484488 cites W2052739616 @default.
• W2080484488 cites W2057476623 @default.
• W2080484488 cites W2057647944 @default.
• W2080484488 cites W2061682040 @default.
• W2080484488 cites W2065069831 @default.
• W2080484488 cites W2068592034 @default.
• W2080484488 cites W2074282824 @default.
• W2080484488 cites W2075877458 @default.
• W2080484488 cites W2079430155 @default.
• W2080484488 cites W2083450984 @default.
• W2080484488 cites W2093974020 @default.
• W2080484488 cites W2097158347 @default.
• W2080484488 cites W2111299679 @default.
• W2080484488 cites W2123599709 @default.
• W2080484488 cites W2127662109 @default.
• W2080484488 cites W2130660971 @default.
• W2080484488 cites W2142240784 @default.
• W2080484488 cites W2148958087 @default.
• W2080484488 cites W2155467153 @default.
• W2080484488 cites W2157725602 @default.
• W2080484488 cites W2168691128 @default.
• W2080484488 cites W2170155793 @default.
• W2080484488 cites W2257166552 @default.
• W2080484488 cites W2312463092 @default.
• W2080484488 doi "https://doi.org/10.1016/j.vaccine.2010.06.065" @default.
• W2080484488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20600478" @default.
• W2080484488 hasPublicationYear "2010" @default.
• W2080484488 type Work @default.
• W2080484488 sameAs 2080484488 @default.
• W2080484488 citedByCount "90" @default.
• W2080484488 countsByYear W20804844882012 @default.
• W2080484488 countsByYear W20804844882013 @default.
• W2080484488 countsByYear W20804844882014 @default.
• W2080484488 countsByYear W20804844882015 @default.
• W2080484488 countsByYear W20804844882016 @default.
• W2080484488 countsByYear W20804844882017 @default.
• W2080484488 countsByYear W20804844882018 @default.
• W2080484488 countsByYear W20804844882019 @default.
• W2080484488 countsByYear W20804844882021 @default.
• W2080484488 countsByYear W20804844882023 @default.
• W2080484488 crossrefType "journal-article" @default.
• W2080484488 hasAuthorship W2080484488A5009849024 @default.
• W2080484488 hasAuthorship W2080484488A5010388039 @default.
• W2080484488 hasAuthorship W2080484488A5053911746 @default.
• W2080484488 hasAuthorship W2080484488A5057302487 @default.
• W2080484488 hasAuthorship W2080484488A5064375375 @default.
• W2080484488 hasAuthorship W2080484488A5076616385 @default.
• W2080484488 hasAuthorship W2080484488A5085621907 @default.
• W2080484488 hasAuthorship W2080484488A5091003508 @default.
• W2080484488 hasConcept C126322002 @default.
• W2080484488 hasConcept C159047783 @default.
• W2080484488 hasConcept C159654299 @default.
• W2080484488 hasConcept C182072434 @default.
• W2080484488 hasConcept C197934379 @default.
• W2080484488 hasConcept C203014093 @default.
• W2080484488 hasConcept C22070199 @default.
• W2080484488 hasConcept C2777451964 @default.
• W2080484488 hasConcept C2777704310 @default.
• W2080484488 hasConcept C2778562196 @default.
• W2080484488 hasConcept C2780689484 @default.
• W2080484488 hasConcept C2780820931 @default.
• W2080484488 hasConcept C2780868878 @default.
• W2080484488 hasConcept C2909469553 @default.
• W2080484488 hasConcept C32611913 @default.
• W2080484488 hasConcept C71924100 @default.
• W2080484488 hasConcept C8891405 @default.
• W2080484488 hasConceptScore W2080484488C126322002 @default.
• W2080484488 hasConceptScore W2080484488C159047783 @default.
• W2080484488 hasConceptScore W2080484488C159654299 @default.
• W2080484488 hasConceptScore W2080484488C182072434 @default.

• next